Literature DB >> 1644665

Differential expression of vinculin between weakly and highly metastatic B16-melanoma cell lines.

H Sadano1, M Inoue, S Taniguchi.   

Abstract

We previously reported on the altered expression of a third actin in mouse-B16 melanoma associated with malignant progression. While further investigating the relationship of cytoskeletal proteins to malignancy, we found that the expression of vinculin was higher in weakly metastatic B16-F1 cells than in highly metastatic B16-F10 cells. By Northern blot analysis, the mRNA expression of vinculin in B16-F1 was also shown to be higher than in B16-F10. Immunofluorescence staining showed a clear dotted distribution of vinculin in B16-F1, but only a weak and diffuse distribution in B16-F10. The dotted distribution tended to be larger in B16-F1 and when cultured on Matrigel and fibronectin than on laminin and type IV collagen. An alteration in the expression of vinculin was also observed in other cell systems. Vinculin was detected in both normal 3Y1 and in relatively weakly malignant transformed 3Y1 cell lines, while vinculin was either scarcely detected or not detected at all in more malignant cell lines. These results suggest that the suppression of vinculin is closely related to malignant progression in both the B16-melanoma and 3Y1 cell systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644665      PMCID: PMC5918885          DOI: 10.1111/j.1349-7006.1992.tb00135.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  Newly identified type of beta actin reduces invasiveness of mouse B16-melanoma.

Authors:  H Sadano; S Taniguchi; T Baba
Journal:  FEBS Lett       Date:  1990-10-01       Impact factor: 4.124

2.  Effects of the src gene product on microfilament and microtubule organization in avian and mammalian cells infected with the same temperature-sensitive mutant of Rous sarcoma virus.

Authors:  E Wang; A R Goldberg
Journal:  Virology       Date:  1979-01-15       Impact factor: 3.616

3.  High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line.

Authors:  S Taniguchi; M Tatsuka; K Nakamatsu; M Inoue; H Sadano; H Okazaki; H Iwamoto; T Baba
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

4.  Patterns of organization of actin and myosin in normal and transformed cultured cells.

Authors:  R Pollack; M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

Review 5.  Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton.

Authors:  K Burridge; K Fath; T Kelly; G Nuckolls; C Turner
Journal:  Annu Rev Cell Biol       Date:  1988

6.  Selective cytotoxicity of phospholipids and diacylglycerols to rat 3Y1 fibroblasts transformed by adenovirus type 12 or its E1A gene.

Authors:  H Shimura; M Ohtsu; A Matsuzaki; T Mitsudomi; K Onodera; G Kimura
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

7.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

8.  A 130K protein from chicken gizzard: its localization at the termini of microfilament bundles in cultured chicken cells.

Authors:  B Geiger
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

9.  Vinculin: a cytoskeletal target of the transforming protein of Rous sarcoma virus.

Authors:  B M Sefton; T Hunter; E H Ball; S J Singer
Journal:  Cell       Date:  1981-04       Impact factor: 41.582

10.  Alteration in expression of smooth muscle alpha-actin associated with transformation of rat 3Y1 cells.

Authors:  M Okamoto-Inoue; S Taniguchi; H Sadano; T Kawano; G Kimura; G Gabbiani; T Baba
Journal:  J Cell Sci       Date:  1990-08       Impact factor: 5.285

View more
  9 in total

1.  The endogenous progesterone metabolite, 5a-pregnane-3,20-dione, decreases cell-substrate attachment, adhesion plaques, vinculin expression, and polymerized F-actin in MCF-7 breast cancer cells.

Authors:  J P Wiebe; D Muzia
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

Review 2.  New insights into vinculin function and regulation.

Authors:  Xiao Peng; Elke S Nelson; Jessica L Maiers; Kris A DeMali
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

3.  Complete Model of Vinculin Suggests the Mechanism of Activation by Helical Super-Bundle Unfurling.

Authors:  Dominik L Stec; Boguslaw Stec
Journal:  Protein J       Date:  2022-01-10       Impact factor: 2.371

4.  Vinculin regulates cell-surface E-cadherin expression by binding to beta-catenin.

Authors:  Xiao Peng; Laura E Cuff; Cort D Lawton; Kris A DeMali
Journal:  J Cell Sci       Date:  2010-01-19       Impact factor: 5.285

5.  Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.

Authors:  Charlotte Welinder; Krzysztof Pawłowski; A Marcell Szasz; Maria Yakovleva; Yutaka Sugihara; Johan Malm; Göran Jönsson; Christian Ingvar; Lotta Lundgren; Bo Baldetorp; Håkan Olsson; Melinda Rezeli; Thomas Laurell; Elisabet Wieslander; György Marko-Varga
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

6.  Adhesion strength and anti-tumor agents regulate vinculin of breast cancer cells.

Authors:  Despoina Nektaria Metsiou; Despina Deligianni; Efstathia Giannopoulou; Haralabos Kalofonos; Angelos Koutras; George Athanassiou
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

7.  Intracellular localization and biochemical function of variant beta-actin, which inhibits metastasis of B16 melanoma.

Authors:  H Sadano; R Shimokawa-Kuroki; S Taniguchi
Journal:  Jpn J Cancer Res       Date:  1994-07

8.  Inhibition of tumor cell haptotaxis by sodium D-glucaro-delta-lactam (ND2001).

Authors:  T Tsuruoka; M Azetaka; Y Iizuka; K Saito; S Inouye; M Hosokawa; H Kobayashi
Journal:  Jpn J Cancer Res       Date:  1995-11

9.  Combined Toxicity of Gas Plasma Treatment and Nanoparticles Exposure in Melanoma Cells In Vitro.

Authors:  Sander Bekeschus
Journal:  Nanomaterials (Basel)       Date:  2021-03-22       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.